IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,214	2,293	874	910	407	151
Market Cap Growth	72.34%	162.34%	-3.92%	123.69%	168.50%	-
Enterprise Value	1,032	1,784	484	530	125	49
Last Close Price	25.61	35.58	18.17	23.64	14.00	7.50
PS Ratio	682.40	98.07	17.16	32.57	20.82	-
PB Ratio	1.87	3.69	2.50	3.02	2.05	1.51
P/TBV Ratio	2.27	3.69	2.50	3.02	2.05	1.51
P/FCF Ratio	-	-	-	-	7.40	-
P/OCF Ratio	-	-	-	-	7.33	-
EV/Sales Ratio	263.17	76.31	9.51	18.96	6.40	-
EV/FCF Ratio	-	-	-	-	2.27	-
Debt / Equity Ratio	0.02	0.00	0.01	0.02	0.03	0.07
Debt / FCF Ratio	-	-	-	-	0.12	-
Asset Turnover	0.00	0.05	0.13	0.08	0.10	-
Quick Ratio	22.63	19.38	11.51	5.49	7.39	14.26
Current Ratio	22.93	19.65	11.68	5.56	7.47	14.65
Return on Equity (ROE)	-21.10%	-23.28%	-18.02%	-19.91%	-23.10%	-44.22%
Return on Assets (ROA)	-15.85%	-16.20%	-10.16%	-9.25%	-10.74%	-26.41%
Return on Capital (ROIC)	-16.44%	-17.20%	-11.84%	-12.28%	-14.15%	-28.15%
Earnings Yield	-8.05%	-4.93%	-6.71%	-5.47%	-8.48%	-27.71%
FCF Yield	-6.92%	-5.13%	-10.37%	-6.42%	13.51%	-26.84%
Buyback Yield / Dilution	-43.06%	-38.79%	-17.57%	-42.60%	-97.82%	-1206.87%
Total Shareholder Return	-43.06%	-38.79%	-17.57%	-42.60%	-97.82%	-1206.87%

Source: S&P Capital IQ. Standard template. Financial Sources.